M&A · Acquisition · Completed

OpenAI acquires Orchestra Bio

OpenAI acquired Orchestra Bio and plans to combine its drug-development coordination platform with OpenAI’s Rosalind models and tools for life-sciences research.

Completed Oct 20, 2026Reviewed Nov 12, 2026Event ID evt_openai_orchestra_bio_acquisition_2026

Participants

Roles as the source names them

Organization	Role	Type	Note
OpenAI	Acquirer	AI lab	—
Orchestra Bio	Target	AI app	—

Key terms

Acquisition: OpenAI acquired Orchestra Bio, a drug-development coordination platform. OpenAI ↗
“OpenAI has acquired Orchestra Bio”
Integration: OpenAI is bringing Orchestra’s team and technology together with Rosalind. OpenAI ↗
“We're bringing Orchestra's team and technology together with Rosalind, our AI models and tools for life sciences research.”

Sources

OpenAI, “OpenAI acquires Orchestra Bio”, Oct 20, 2026 · retrieved Nov 12, 2026

Corrections: none. Found an error? Report it.